Search details
1.
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer.
Nature
; 603(7903): 942-948, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35322232
2.
Integrating Patient-Reported Outcomes Into Prognostication in Gastroesophageal Cancer: Results of a Population-Based Retrospective Cohort Analysis.
Oncologist
; 29(4): 316-323, 2024 Apr 04.
Article
in English
| MEDLINE | ID: mdl-38431782
3.
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
N Engl J Med
; 384(13): 1191-1203, 2021 04 01.
Article
in English
| MEDLINE | ID: mdl-33789008
4.
Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: a real-world analysis of clinical and pathologic characteristics and outcomes.
J Neurooncol
; 167(1): 111-122, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38372902
5.
Comparison of Four Clinical Prognostic Scores in Patients with Advanced Gastric and Esophageal Cancer.
Oncologist
; 28(3): 214-219, 2023 03 17.
Article
in English
| MEDLINE | ID: mdl-36378560
6.
Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinoma.
Esophagus
; 20(3): 557-566, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36631713
7.
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study.
Lancet Oncol
; 23(12): 1558-1570, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36400106
8.
Impact of Sites of Metastatic Dissemination on Survival in Advanced Gastroesophageal Adenocarcinoma.
Oncology
; 100(8): 439-448, 2022.
Article
in English
| MEDLINE | ID: mdl-35764050
9.
Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer.
Eur J Nucl Med Mol Imaging
; 49(3): 1012-1020, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34491404
10.
Preoperative and Postoperative Approaches to Gastroesophageal Cancer: What is All the Fuss About.
J Natl Compr Canc Netw
; 20(2): 193-202, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35130503
11.
HERIZON-GEA-01: Zanidatamab + chemo ± tislelizumab for 1L treatment of HER2-positive gastroesophageal adenocarcinoma.
Future Oncol
; 18(29): 3255-3266, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-36000541
12.
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer.
Oncology
; 99(1): 49-56, 2021.
Article
in English
| MEDLINE | ID: mdl-33053548
13.
Patient-derived organoids for prediction of treatment response in oesophageal adenocarcinoma.
Br J Surg
; 111(1)2024 Jan 03.
Article
in English
| MEDLINE | ID: mdl-38284787
14.
Ramucirumab and Paclitaxel Administered Every 2 Weeks (mRAINBOW Regimen) in Advanced Gastroesophageal Adenocarcinoma.
Oncology
; 96(5): 252-258, 2019.
Article
in English
| MEDLINE | ID: mdl-30893708
15.
Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial.
Br J Cancer
; 118(3): 331-337, 2018 02 06.
Article
in English
| MEDLINE | ID: mdl-29235564
16.
Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large Cohort.
Oncology
; 94(6): 345-353, 2018.
Article
in English
| MEDLINE | ID: mdl-29705797
17.
Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients.
Br J Cancer
; 117(5): 648-655, 2017 Aug 22.
Article
in English
| MEDLINE | ID: mdl-28728163
18.
Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma.
Ann Surg Oncol
; 24(8): 2291-2301, 2017 Aug.
Article
in English
| MEDLINE | ID: mdl-27770339
19.
Current status of ramucirumab in gastroesophageal adenocarcinoma.
Future Oncol
; 13(18): 1585-1592, 2017 Aug.
Article
in English
| MEDLINE | ID: mdl-28436242
20.
Exploiting Molecular and Immune Biology of Gastric and Gastroesophageal Adenocarcinomas to Discover Novel Therapeutic Targets.
Ann Surg Oncol
; 23(12): 3786-3791, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27503493